NASDAQ : TRDA
Entrada Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 4.4 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 158.65M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Entrada Therapeutics, Inc. (TRDA) reported revenue of 4.69M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 4.69M | 25.42M | 210.78M | 129.01M | ||
| Cost of Revenue | 139.04M | 140.57M | 125.31M | 99.88M | 66.61M | 35.93M |
| Gross Profit | -134.35M | -115.15M | 85.48M | 29.13M | -66.61M | -35.93M |
| Selling, General & Admin | 40.27M | 40.85M | 38.47M | 32.29M | 30.64M | 15.20M |
| Operating Expenses | 40.27M | 40.85M | 38.47M | 32.29M | 30.64M | 15.20M |
| Operating Income | -174.62M | -156.00M | 47.01M | -3.16M | -97.25M | -51.13M |
| Interest & Investment Income | 11.57M | 15.07M | 19.47M | 15.22M | 2.63M | 43.00K |
| EBT Excluding Unusual Items | -163.06M | -140.93M | 66.48M | 12.06M | -94.62M | -51.08M |
| Merger & Restructuring Charges | -1.90M | -1.90M | ||||
| Gain (Loss) on Sale of Assets | -74.00K | |||||
| Pretax Income | -164.96M | -142.83M | 66.48M | 12.06M | -94.62M | -51.16M |
| Income Tax Expense | 819.00K | 924.00K | 859.00K | 18.74M | ||
| Net Income | -165.78M | -143.75M | 65.63M | -6.68M | -94.62M | -51.16M |
| Net Income to Common | -165.78M | -143.75M | 65.63M | -6.68M | -94.62M | -51.16M |
| Shares Outstanding (Basic) | 41.78M | 41.37M | 37.31M | 33.05M | 31.29M | 6.27M |
| Shares Outstanding (Diluted) | 41.78M | 41.37M | 39.00M | 33.05M | 31.29M | 6.27M |
| EPS (Basic) | -3.97 | -3.47 | 1.76 | -0.20 | -3.02 | -8.16 |
| EPS (Diluted) | -3.97 | -3.47 | 1.68 | -0.20 | -3.02 | -8.16 |
| Free Cash Flow | -134.35M | -129.55M | -44.72M | 134.19M | -96.67M | -55.44M |
| Free Cash Flow Per Share | -3.21 | -3.13 | -1.15 | 4.06 | -3.09 | -8.85 |
| Gross Margin | 40.55% | 22.58% | ||||
| Operating Margin | -3,726.53% | -613.66% | 22.30% | -2.45% | ||
| Profit Margin | -3,537.73% | -565.48% | 31.14% | -5.18% | ||
| Free Cash Flow Margin | -2,867.07% | -509.63% | -21.21% | 104.01% | ||
| EBITDA | -170.86M | -151.90M | 50.78M | -321.00K | -95.35M | -50.01M |
| EBITDA Margin | 24.09% | -0.25% | ||||
| D&A For EBITDA | 3.76M | 4.10M | 3.77M | 2.84M | 1.90M | 1.12M |
| EBIT | -174.62M | -156.00M | 47.01M | -3.16M | -97.25M | -51.13M |
| EBIT Margin | 22.30% | -2.45% | ||||
| Effective Tax Rate | 1.29% | 155.45% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 99.28M | 90.39M | 101.21M | 67.60M | 45.16M | 291.06M |
| Short-Term Investments | 123.72M | 205.30M | 318.79M | 284.37M | 143.56M | |
| Cash & Short-Term Investments | 223.00M | 295.70M | 420.00M | 351.97M | 188.71M | 291.06M |
| Accounts Receivable | 816.00K | 1.18M | 3.68M | 5.88M | ||
| Other Receivables | 900.00K | 1.40M | 1.80M | 1.70M | 600.00K | |
| Receivables | 1.72M | 2.58M | 5.48M | 7.58M | 600.00K | |
| Prepaid Expenses | 7.98M | 7.32M | 14.56M | 10.22M | 20.56M | 7.64M |
| Restricted Cash | 658.00K | |||||
| Total Current Assets | 232.70M | 306.25M | 440.04M | 369.77M | 209.88M | 298.70M |
| Property, Plant & Equipment | 62.76M | 67.76M | 82.05M | 92.68M | 33.02M | 6.26M |
| Other Long-Term Assets | 3.41M | 3.36M | 4.23M | 6.74M | 9.16M | 872.00K |
| Total Assets | 298.88M | 377.38M | 526.32M | 469.19M | 252.06M | 305.83M |
| Accounts Payable | 3.75M | 2.29M | 4.26M | 3.28M | 5.99M | 706.00K |
| Accrued Expenses | 12.33M | 16.51M | 12.30M | 10.32M | 7.14M | 5.53M |
| Current Portion of Leases | 4.45M | 4.14M | 7.56M | 7.91M | 8.41M | |
| Current Income Taxes Payable | 667.00K | 4.02M | ||||
| Current Unearned Revenue | 173.00K | 342.00K | 13.65M | 132.26M | ||
| Other Current Liabilities | 672.00K | 1.17M | 1.04M | 1.00M | 431.00K | 485.00K |
| Total Current Liabilities | 21.37M | 24.45M | 39.48M | 158.80M | 21.97M | 6.72M |
| Long-Term Leases | 44.09M | 46.79M | 51.65M | 60.32M | 17.53M | |
| Long-Term Unearned Revenue | 6.51M | 7.71M | ||||
| Other Long-Term Liabilities | 396.00K | |||||
| Total Liabilities | 65.47M | 71.25M | 97.64M | 226.83M | 39.50M | 7.12M |
| Common Stock | 4.00K | 4.00K | 4.00K | 3.00K | 3.00K | 3.00K |
| Additional Paid-In Capital | 588.91M | 578.57M | 558.06M | 437.13M | 402.89M | 392.38M |
| Retained Earnings | -355.57M | -273.09M | -129.34M | -194.97M | -188.28M | -93.67M |
| Comprehensive Income & Other | 66.00K | 652.00K | -43.00K | 195.00K | -2.06M | |
| Total Common Equity | 233.41M | 306.13M | 428.68M | 242.36M | 212.55M | 298.72M |
| Shareholders' Equity | 233.41M | 306.13M | 428.68M | 242.36M | 212.55M | 298.72M |
| Total Liabilities & Equity | 298.88M | 377.38M | 526.32M | 469.19M | 252.06M | 305.83M |
| Total Debt | 48.54M | 50.93M | 59.21M | 68.23M | 25.94M | |
| Net Cash (Debt) | 174.46M | 244.77M | 360.79M | 283.74M | 162.78M | 291.06M |
| Net Cash Per Share | 4.18 | 5.92 | 9.25 | 8.59 | 5.20 | 46.44 |
| Filing Date Shares Outstanding | 36.06M | 36.00M | 35.63M | 32.33M | 33.08M | 31.25M |
| Total Common Shares Outstanding | 36.06M | 36.00M | 35.61M | 32.17M | 31.39M | 31.22M |
| Working Capital | 211.33M | 281.80M | 400.56M | 210.97M | 187.90M | 291.98M |
| Book Value Per Share | 6.47 | 8.50 | 12.04 | 7.53 | 6.77 | 9.57 |
| Tangible Book Value | 233.41M | 306.13M | 428.68M | 242.36M | 212.55M | 298.72M |
| Tangible Book Value Per Share | 6.47 | 8.50 | 12.04 | 7.53 | 6.77 | 9.57 |
| Machinery | 16.22M | 17.06M | 18.42M | 15.26M | 8.54M | 6.12M |
| Construction In Progress | 584.00K | |||||
| Leasehold Improvements | 187.00K | 187.00K | 1.93M | 1.86M | 1.86M | 1.56M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -165.78M | -143.75M | 65.63M | -6.68M | -94.62M | -51.16M |
| Depreciation & Amortization | 3.76M | 4.10M | 3.77M | 2.84M | 1.90M | 1.12M |
| Loss (Gain) From Sale of Assets | 74.00K | |||||
| Loss (Gain) From Sale of Investments | -2.37M | -3.67M | -10.02M | -5.78M | 151.00K | |
| Stock-Based Compensation | 19.37M | 19.61M | 17.91M | 13.11M | 9.89M | 2.53M |
| Change in Accounts Receivable | 364.00K | 2.50M | 2.20M | -5.88M | ||
| Change in Accounts Payable | 1.89M | -1.80M | 991.00K | -2.81M | 5.29M | -715.00K |
| Change in Unearned Revenue | -710.00K | -19.82M | -119.81M | 139.98M | ||
| Change in Income Taxes | -667.00K | -3.36M | 4.02M | |||
| Change in Other Net Operating Assets | 8.80M | 14.99M | 1.12M | 998.00K | -16.40M | -2.71M |
| Operating Cash Flow | -134.67M | -128.51M | -41.56M | 139.80M | -93.79M | -50.86M |
| Capital Expenditures | 323.00K | -1.04M | -3.16M | -5.61M | -2.89M | -4.58M |
| Investment in Securities | 159.84M | 117.85M | -24.64M | -132.78M | -145.76M | |
| Investing Cash Flow | 160.16M | 116.81M | -27.80M | -138.40M | -148.65M | -4.58M |
| Issuance of Common Stock | 650.00K | 887.00K | 102.96M | 21.04M | 479.00K | 191.63M |
| Financing Cash Flow | 650.00K | 887.00K | 102.96M | 21.04M | 479.00K | 307.46M |
| Net Cash Flow | 26.14M | -10.82M | 33.61M | 22.45M | -241.96M | 252.02M |
| Free Cash Flow | -134.35M | -129.55M | -44.72M | 134.19M | -96.67M | -55.44M |
| Free Cash Flow Margin | -2,867.07% | -509.63% | -21.21% | 104.01% | ||
| Free Cash Flow Per Share | -3.21 | -3.13 | -1.15 | 4.06 | -3.09 | -8.85 |
| Levered Free Cash Flow | -77.67M | -76.96M | -73.29M | 149.04M | -58.56M | -36.26M |
| Unlevered Free Cash Flow | -77.67M | -76.96M | -73.29M | 149.04M | -58.56M | -36.26M |
| Cash Income Tax Paid | 1.70M | 1.70M | 4.62M | 14.72M | ||
| Change in Working Capital | 10.34M | -4.80M | -118.85M | 136.31M | -11.11M | -3.42M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 166.22M | 368.66M | 612.16M | 503.01M | 423.70M | 534.36M |
| Enterprise Value | -8.24M | 94.22M | 224.13M | 218.50M | 236.07M | 609.68M |
| Last Close Price | 4.54 | 10.28 | 17.29 | 15.09 | 13.52 | 17.12 |
| PE Ratio | 9.33 | |||||
| PS Ratio | 34.90 | 14.50 | 2.90 | 3.90 | ||
| PB Ratio | 0.70 | 1.20 | 1.43 | 2.08 | 1.99 | 1.79 |
| P/TBV Ratio | 0.70 | 1.20 | 1.43 | 2.08 | 1.99 | 1.79 |
| P/FCF Ratio | 3.75 | |||||
| P/OCF Ratio | 3.60 | |||||
| EV/Sales Ratio | 3.71 | 1.06 | 1.69 | |||
| EV/EBITDA Ratio | 4.41 | |||||
| EV/EBIT Ratio | 4.77 | |||||
| EV/FCF Ratio | 1.63 | |||||
| Debt / Equity Ratio | 0.21 | 0.17 | 0.14 | 0.28 | 0.12 | |
| Debt / EBITDA Ratio | 0.92 | 4.68 | ||||
| Debt / FCF Ratio | 0.51 | |||||
| Net Debt / Equity Ratio | -0.75 | -0.80 | -0.84 | -1.17 | -0.77 | -0.97 |
| Net Debt / EBITDA Ratio | 1.02 | 1.61 | -7.10 | 883.92 | 1.71 | 5.82 |
| Net Debt / FCF Ratio | 1.30 | 1.89 | 8.07 | -2.11 | 1.68 | 5.25 |
| Asset Turnover | 0.01 | 0.06 | 0.42 | 0.36 | ||
| Quick Ratio | 10.52 | 12.20 | 10.78 | 2.26 | 8.62 | 43.32 |
| Current Ratio | 10.89 | 12.53 | 11.14 | 2.33 | 9.55 | 44.46 |
| Return on Equity (ROE) | -54.10% | -39.13% | 19.56% | -2.94% | -37.01% | -30.19% |
| Return on Assets (ROA) | -29.20% | -21.58% | 5.90% | -0.55% | -21.79% | -18.29% |
| Return on Invested Capital (ROIC) | -280.08% | -241.38% | 68.35% | -195.36% | ||
| Return on Capital Employed (ROCE) | -62.90% | -44.20% | 9.70% | -1.00% | -42.30% | -17.10% |
| Earnings Yield | -86.06% | -38.99% | 10.72% | -1.33% | -22.33% | -9.57% |
| FCF Yield | -82.16% | -35.14% | -7.30% | 26.68% | -22.82% | -10.38% |
| Buyback Yield / Dilution | -1.93% | -6.07% | -18.01% | -5.62% | -399.27% | -467.09% |